Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Regulation of laboratory-developed tests: the case for utilizing professional associations.

Hockett RD, Close SL.

Clin Pharmacol Ther. 2010 Dec;88(6):743-5. doi: 10.1038/clpt.2010.248. Review. No abstract available.

PMID:
21081941
2.

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.

Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias WL, Braunwald E, Sabatine MS.

Circulation. 2009 May 19;119(19):2553-60. doi: 10.1161/CIRCULATIONAHA.109.851949. Epub 2009 May 4.

PMID:
19414633
3.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS.

N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22.

4.

4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007.

Frueh FW, Salerno RA, Lesko LJ, Hockett RD.

Pharmacogenomics. 2009 Jan;10(1):111-5. doi: 10.2217/14622416.10.1.111.

PMID:
19102720
5.

Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?".

Llerena A, Michel G, Jeannesson E, Wong S, Manolopoulos VG, Hockett RD, Boubekeur K, Siest G, Beaune P, Haefliger C, Arnold HP, Junien C, Petrovic N, Molloy R, Bekers O, Donnelly C, Arens HJ, Kaput J, McComb J.

Clin Chem Lab Med. 2007;45(7):843-50.

PMID:
17617025
6.

Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport.

Daly TM, Dumaual CM, Miao X, Farmen MW, Njau RK, Fu DJ, Bauer NL, Close S, Watanabe N, Bruckner C, Hardenbol P, Hockett RD.

Clin Chem. 2007 Jul;53(7):1222-30. Epub 2007 May 17.

7.

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping System.

Dumaual C, Miao X, Daly TM, Bruckner C, Njau R, Fu DJ, Close-Kirkwood S, Bauer N, Watanabe N, Hardenbol P, Hockett RD.

Pharmacogenomics. 2007 Mar;8(3):293-305. Review.

PMID:
17324118
8.

A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.

Gomez HL, Santillana SL, Vallejos CS, Velarde R, Sanchez J, Wang X, Bauer NL, Hockett RD, Chen VJ, Niyikiza C, Hanauske AR.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):832-8.

9.

The External RNA Controls Consortium: a progress report.

Baker SC, Bauer SR, Beyer RP, Brenton JD, Bromley B, Burrill J, Causton H, Conley MP, Elespuru R, Fero M, Foy C, Fuscoe J, Gao X, Gerhold DL, Gilles P, Goodsaid F, Guo X, Hackett J, Hockett RD, Ikonomi P, Irizarry RA, Kawasaki ES, Kaysser-Kranich T, Kerr K, Kiser G, Koch WH, Lee KY, Liu C, Liu ZL, Lucas A, Manohar CF, Miyada G, Modrusan Z, Parkes H, Puri RK, Reid L, Ryder TB, Salit M, Samaha RR, Scherf U, Sendera TJ, Setterquist RA, Shi L, Shippy R, Soriano JV, Wagar EA, Warrington JA, Williams M, Wilmer F, Wilson M, Wolber PK, Wu X, Zadro R; External RNA Controls Consortium.

Nat Methods. 2005 Oct;2(10):731-4.

PMID:
16179916
10.

Precision profiling and components of variability analysis for Affymetrix microarray assays run in a clinical context.

Daly TM, Dumaual CM, Dotson CA, Farmen MW, Kadam SK, Hockett RD.

J Mol Diagn. 2005 Aug;7(3):404-12.

11.

Pharmacogenomic biomarkers.

Kirkwood SC, Hockett RD Jr.

Dis Markers. 2002;18(2):63-71. Review.

12.

Pharmacogenomics in endocrinology.

Hockett RD, Kirkwood SC, Mitlak BH, Dere WH.

J Clin Endocrinol Metab. 2002 Jun;87(6):2495-9. Review. No abstract available.

PMID:
12050204
13.

Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members.

Dzialo-Hatton R, Milbrandt J, Hockett RD Jr, Weaver CT.

J Immunol. 2001 Apr 1;166(7):4534-42.

14.

Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR.

Hockett RD Jr, Saag MS, Kilby JM, Sfakianos G, Wakefield TB, Bucy RP.

J Virol Methods. 2000 Jun;87(1-2):1-12.

PMID:
10856747
15.

Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.

Derdeyn CA, Kilby JM, Miralles GD, Li LF, Sfakianos G, Saag MS, Hockett RD, Bucy RP.

J Infect Dis. 1999 Dec;180(6):1851-62.

PMID:
10558941
16.

Interleukin-2 expression by a subpopulation of primary T cells is linked to enhanced memory/effector function.

Saparov A, Wagner FH, Zheng R, Oliver JR, Maeda H, Hockett RD, Weaver CT.

Immunity. 1999 Sep;11(3):271-80.

17.

Characterization of an avian (Gallus gallus domesticus) TCR alpha delta gene locus.

Kubota T, Wang J, Göbel TW, Hockett RD, Cooper MD, Chen CH.

J Immunol. 1999 Oct 1;163(7):3858-66.

18.

Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assay.

Waites KB, Smith KR, Crum MA, Hockett RD, Wells AH, Hook EW 3rd.

J Clin Microbiol. 1999 Sep;37(9):3072-3.

19.

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

Hockett RD, Kilby JM, Derdeyn CA, Saag MS, Sillers M, Squires K, Chiz S, Nowak MA, Shaw GM, Bucy RP.

J Exp Med. 1999 May 17;189(10):1545-54.

20.

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM.

J Clin Invest. 1999 May 15;103(10):1391-8.

21.

T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool.

Kong FK, Chen CL, Six A, Hockett RD, Cooper MD.

Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1536-40.

22.

Stability of RNA molecules stored in GITC.

Gilleland RC, Hockett RD Jr.

Biotechniques. 1998 Dec;25(6):944-6, 948. No abstract available.

24.

Heterogeneity in the clonal T cell response. Implications for models of T cell activation and cytokine phenotype development.

Weaver CT, Saparov A, Kraus LA, Rogers WO, Hockett RD, Bucy RP.

Immunol Res. 1998;17(3):279-302. Review.

PMID:
9638473
25.

Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis.

Roberts FA, Hockett RD Jr, Bucy RP, Michalek SM.

Oral Microbiol Immunol. 1997 Dec;12(6):336-44.

PMID:
9573807
26.

Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts.

Kent LW, Rahemtulla F, Hockett RD Jr, Gilleland RC, Michalek SM.

Infect Immun. 1998 Feb;66(2):608-14.

27.

Identification of a DNA segment exhibiting rearrangement modifying effects upon transgenic delta-deleting elements.

Janowski KM, Ledbetter S, Mayo MS, Hockett RD Jr.

J Exp Med. 1997 Jul 7;186(1):91-100.

28.

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

Kim M, Wright M, Deshane J, Accavitti MA, Tilden A, Saleh M, Vaughan WP, Carabasi MH, Rogers MD, Hockett RD Jr, Grizzle WE, Curiel DT.

Hum Gene Ther. 1997 Jan 20;8(2):157-70.

PMID:
9017419
29.

The effects of dihydrotestosterone on the expression of p185(erbB-2) and c-erbB-2 mRNA in the prostatic cell line LNCaP.

Myers RB, Oelschlager DK, Hockett RD, Rogers MD, Conway-Myers BA, Grizzle WE.

J Steroid Biochem Mol Biol. 1996 Dec;59(5-6):441-7.

PMID:
9010349
31.

A delta T-cell receptor deleting element transgenic reporter construct is rearranged in alpha beta but not gamma delta T-cell lineages.

Shutter J, Cain JA, Ledbetter S, Rogers MD, Hockett RD Jr.

Mol Cell Biol. 1995 Dec;15(12):7022-31.

32.

Simultaneous quantitation of multiple cytokine mRNAs by RT-PCR utilizing plate based EIA methodology.

Hockett RD Jr, Janowski KM, Bucy RP.

J Immunol Methods. 1995 Dec 1;187(2):273-85.

PMID:
7499887
33.

The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24.

Zutter M, Hockett RD, Roberts CW, McGuire EA, Bloomstone J, Morton CC, Deaven LL, Crist WM, Carroll AJ, Korsmeyer SJ.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):3161-5.

34.

Evolutionary comparison of murine and human delta T-cell receptor deleting elements.

Hockett RD Jr, Nuñez G, Korsmeyer SJ.

New Biol. 1989 Dec;1(3):266-74.

PMID:
2535037
35.

Severe paravalvular mechanical hemolysis with a normal blood smear.

Hockett RD Jr, Krewson L, Weiss A, Chaplin H Jr.

Am J Clin Pathol. 1989 Oct;92(4):513-5.

PMID:
2801615
36.
37.

Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene.

Bora NS, Lublin DM, Kumar BV, Hockett RD, Holers VM, Atkinson JP.

J Exp Med. 1989 Feb 1;169(2):597-602.

38.

Human T-cell antigen receptor (TCR) delta-chain locus and elements responsible for its deletion are within the TCR alpha-chain locus.

Hockett RD, de Villartay JP, Pollock K, Poplack DG, Cohen DI, Korsmeyer SJ.

Proc Natl Acad Sci U S A. 1988 Dec;85(24):9694-8.

39.

Deletion of the human T-cell receptor delta-gene by a site-specific recombination.

de Villartay JP, Hockett RD, Coran D, Korsmeyer SJ, Cohen DI.

Nature. 1988 Sep 8;335(6186):170-4.

PMID:
2842691
40.

Human delta T cell receptor: rearrangement, deletion, and translocation.

Korsmeyer SJ, Hockett RD, McGuire EA, Nunez G.

Princess Takamatsu Symp. 1988;19:137-45.

PMID:
2978616
41.

Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.

Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ.

EMBO J. 1988 Jan;7(1):123-31.

42.

Extending the capabilities of a laboratory computer system through cooperative processing.

Parvin CA, Hockett RD.

J Med Syst. 1987 Oct;11(5):359-65.

PMID:
3694074

Supplemental Content

Loading ...
Support Center